ArticleFrontiers in neuroscience2026
Segmentation and structural connectivity of the putamen for targeted convection enhanced drug delivery in Parkinson's disease: a tractography-based approach.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Convection-enhanced drug delivery (CED) for Parkinson's disease (PD) is costly, and current methods lack precision, often targeting the entire putamen, leading to inefficient use of resources. Our simulation study explores a more targeted approach, which could reduce treatment costs by focusing therapy on specific putaminal regions, aiming to optimize delivery without compromising efficacy. Methods: Twenty PD patients underwent diffusion-weighted imaging (DWI) to visualize the structural connectivity. A commercial subcortical auto-segmentation tool was used to define the putamen as well as the amygdala, the STN, and the cerebellum. Utilizing the Julich Brain Atlas, nine cortical regions (Brodmann areas 44, 45, 3a/b, 4a/p, pre-SMA, SMA, and insula) were semi-automatically segmented. Before tractography, the putamen was pre-parcellated into four segments in relation to the anterior commissure. Tractography was then performed to assess the cortical connectivity of each segment. We evaluated two virtual injection trajectories (occipital and frontal) and simulated stepwise infusions of a therapeutic agent. A genetic algorithm optimized the simulated infusions and compared coverage of the target region. Results: Tractography revealed a significant projection of motor areas to the superior posterior segment of the putamen, suggesting this region as a more specific target for treating motor symptoms in PD via CED. Non-motor connections were most common in the inferior posterior segment for the amygdala and in the superior anterior segment for the insula. Both occipital and frontal trajectories were found to be equally feasible for targeting the putamen segments, with surgical feasibility varying by individual patient anatomy, and achieved comparable coverage, with no significant difference between them, highlighting the need for personalized surgical approaches. Conclusion: DWI-based deterministic tractography mapped motor cortical projections most consistently to the superior-posterior putamen in our AC-based segmentation. In our planning simulations, both frontal and occipital trajectories could be planned with similar safety and achieved similar simulated coverage of the segment. These results support using connectivity mapping and simple simulation as a planning adjunct to help select a motor-dominant putaminal target and compare trajectories. If validated clinically, targeting a motor-dominant segment could reduce exposure of non-motor putaminal regions and potentially reduce the required infusion volume.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.